It is widely recognized that cell death resistance is a hallmark feature of hepatocellular carcinoma, and tumor cells have developed various strategies, such as the loss of TP53 tumor suppressor function, to limit apoptosis, which also plays a pivotal role in the failure of traditional cancer treatment (23, 24). This evidence concerns the gene TP53 and hepatocellular carcinoma.